Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Iodine radioisotope |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodide salt |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine (substance) |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodoform (substance) |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodic acid (substance) |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine compound |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Periodate salt |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodate salt |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chloriodized oil (substance) |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ipodate |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethiodised oil |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopanoic acid (substance) |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Povidone iodine |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing iodine AND/OR iodine compound |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aqueous iodine 130mg/mL oral solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine weak solution BP (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine strong solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing iodine and methyl salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing iodine and isopropyl alcohol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine 0.7%/isopropyl alcohol 74% w/w topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 125mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 300mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 180mg + iodine 85mg/mL (18%) injection solution 300mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 2000mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1000mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1500mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 300mg + iodine 141mg/mL (30%) injection solution 50mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 1250mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 75mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 150mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 175mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Diatrizoate meglumine 600mg + iodine 282mg/mL (60%) injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iopamidol 755mg/mL + iodine 370mg/mL injection solution 30mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodinated contrast media (substance) |
Is a |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine compounds overdose |
Causative agent (attribute) |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iodine-induced hyperthyroidism |
Causative agent (attribute) |
False |
iode et/ou composé iodé |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|